
姓名:田雨 职称:副教授
办公室:医学2201
电子邮件 :1000006331@ujs.edu.cn
系所(中心):江苏大学国际基因组学研究中心
个人简介:
田雨,副教授,硕士生导师,江苏省免疫学会青年工作委员会委员,主要从事心血管疾病的免疫学机制与心肌损伤修复研究,以第一作者/通讯作者发表SCI论文十余篇;主持国家自然科学基金青年基金项目等课题。主讲《免疫学》《医学免疫学》等本硕核心课程。
教育经历:
1. 2016年—2022年,江苏大学,临床检验诊断学,博士
2. 2011年—2016年,青海大学,医学检验(五年制),学士
研究方向:
1. 心血管疾病的免疫学机制与心肌损伤修复,聚焦心脏驻留巨噬细胞、心包脂肪组织(PAT)与固有淋巴样细胞(ILC)在心肌梗死、心肌炎等疾病中的作用;
2. HMGB1及其A box介导的炎症与细胞焦亡调控,以及其在脓毒症、帕金森病等疾病中的致病机制与治疗靶点研究;
3. TREM2在免疫、神经系统疾病及肿瘤微环境中的作用研究;
4. 心外膜脂肪组织在心血管健康与疾病中的双重作用,以及心血管疾病的空间免疫调控。
教学方向:
主讲《免疫学》《医学免疫学》《免疫系统》《细胞与分子免疫学技术》《微生物与免疫学》《高级免疫工程与技术》等6门本科生及研究生核心课程,总学时超过300学时,教学评价均为优秀。
教学奖励:
1. 2026年,江苏大学青年教师教学竞赛,校级二等奖;
2. 2025年,教育部教育技术与资源发展中心,全国师生数字素养提升实践活动高等教育专项,典型作品(主要参与人,2/5);
3. 2024年,江苏大学生命科学学院本科教学能力竞赛,院级二等奖。
科研奖励:
1. 2025年,江苏大学青年英才培育计划(骨干教师)。
科研项目:
1. 国家自然科学基金青年基金项目:心脏驻留TLF+巨噬细胞产生的IGF-1促进心包脂肪组织累积加重心梗心脏损伤的机制研究(2025.1—2027.12,30万元,在研,主持);
2. 江苏省教育厅高校基础科学(自然科学)研究面上项目:心脏驻留TLF+巨噬细胞来源的IGF-1介导PAT累积加重心梗的机制研究(2024.7—2026.7,3万元,在研,主持);
3. 江苏大学—上海儒百生物科技有限公司横向项目:HMGB1 A Box对几种人免疫细胞的影响评测(2023.4.30—2023.12.31,50万元,结题,主持);
4. 江苏省社会发展重点项目(BE2019700):基于CRM基础上的促心肌细胞再生靶点的筛选及在心脏疾病综合防治中的策略研究(2019—2022,200万元,结题,参与);
5. 国家自然科学基金面上项目(81871244):reHMGB1诱导NKp46(+) ILC3扩增分泌IL-22调控EAM小鼠心肌纤维化的研究(2019.1—2022.12,56万元,结题,参与);
6. 2025年民革江苏省委会调研课题:基层医疗单位老年慢性病早期预警与干预模式构建(起草人);
7. 2026年人工智能赋能高等教育新生态专项课题:生成式AI赋能医学基础课程:动态知识图谱与自适应学习机制研究(主持)。
发表论文:
一作/通讯SCI论文:
1. Tian Yu, Cao Yuwen, Liu Fang, Xia Lin, Wang Chao, Su Zhaoliang. Role of Histiocyte-Derived frHMGB1 as a Facilitator in Noncanonical Pyroptosis of Monocytes/Macrophages in Lethal Sepsis. J Infect Dis. 2024.(Nature Index期刊)
2. Tian Yu, Gong Xiangmei, Qin Demeng, et al. S1PR1-dependent migration of ILC3s from intestinal tissue to the heart in a mouse model of viral myocarditis. J Leukoc Biol. 2023.
3. Tian Yu, Chen Rong, Su Zhaoliang. HMGB1 is a Potential and Challenging Therapeutic Target for Parkinson's Disease. Cell Mol Neurobiol. 2021.
4. Tian Yu, Cao Yuwen, Chen Rong, et al. HMGB1 A box protects neurons by potently inhibiting both microglia and T cell-mediated inflammation in a mouse Parkinson's disease model. Clin Sci (Lond). 2020.
5. Tian Yu, Wang Pingping, Dong Zhifeng. Heart-guarding or heart-harming? The dual role of epicardial adipose tissue in cardiovascular health and disease. Int J Obes (Lond). 2025.(Nature Index期刊)
6. Yin Peng, Jiang Haiqiang, Ji Xiaoyun, Xia Lin, Su Zhaoliang, Tian Yu*. Soluble TREM2 Drives Triple-Negative Breast Cancer Progression via Activation of the AKT Pathway. Int Immunopharmacol. 2024.
7. Yin Peng, Su Zhaoliang, Shu Xiaozheng, Dong Zhifeng, Tian Yu*. Role of TREM2 in immune and neurological diseases: Structure, function, and implications. Int Immunopharmacol. 2024.
8. Yin Peng, Cao Pei, Liang Yu, Wang Chao, Tian Yu*. Unlocking the power of innate lymphoid cell plasticity in the tumor microenvironment: A revolutionary pathway for cancer immunotherapy. Biochim Biophys Acta Rev Cancer. 2025.
9. Huang Qining, Jin Jing, Dong Zhifeng, Tian Yu*. Cardiac Innate Lymphoid Cells: The Role of Innate Immune Regulation in Cardiovascular Diseases. Clin Exp Immunol. 2025.
10. Xie Chengchen, Shu Xiaozheng, Wu Yan, Tian Yu*. From cells to niches: Rewiring cardiovascular disease through spatial immunity. Int Immunopharmacol. 2026.
11. Cao Yuwen, Tian Yu#, Liu Yueqin, et al. Reg3β: A Potential Therapeutic Target for Tissue Injury and Inflammation-Associated Disorders. Int Rev Immunol. 2021.
12. Che Yang, Tian Yu#, Chen Rong, et al. IL-22 ameliorated cardiomyocyte apoptosis in cardiac ischemia/reperfusion injury by blocking mitochondrial membrane potential decrease, inhibiting ROS and cytochrome C. Biochim Biophys Acta Mol Basis Dis. 2021.
13. Zhou Lining, Tian Yu#, Guo Fang, et al. LincRNA-p21 knockdown reversed tumor-associated macrophages function by promoting MDM2 to antagonize p53 activation and alleviate breast cancer development. Cancer Immunol Immunother. 2020.
其他论文:
1. Huang Lan, Wan Jie, Wu Yinqiu, Tian Yu, Yao Yizheng, Yao Shun, Ji Xiaoyun, Wang Shengjun, Su Zhaoliang, Xu Huaxi. Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection. Life Sci. 2021.
2. Wan Jie, Wu Yinqiu, Huang Lan, Tian Yu, Ji Xiaoyun, Abdelaziz Mohamed Hamed, Cai Wei, Dineshkumar Kesavan, Lei Yuqing, Yao Shun, Sun Caixia, Su Zhaoliang, Wang Shengjun, Xu Huaxi. ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8 T cells. Cancer Lett. 2021.
3. Li Jiali, Xia Lin, Liu Fang, Tian Yu, Chen Rong, Su Zhaoliang. lncRNA187415.1 silence in BCAMs ameliorated breast cancer progression by blocking C/EBPβ-lncRNA187415.1-CISH axis and reversing pro-tumor characteristic of BCAMs. Clin Transl Med. 2021.
4. Chen Wenli, Yao Shun, Wan Jie, Tian Yu, Huang Lan, Wang Shanshan, Akter Farhana, Wu Yinqiu, Yao Yizheng, Zhang Xiaochun. BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment. J Control Release. 2021.
5. Chen Rong, Liu Fang, Xia Lin, Che Nan, Tian Yu, Cao Yuwen, Zhang Shiqing, Xu Huaxi, Su Zhaoliang. B10 cells decrease fibrosis progression following cardiac injury partially by IL-10 production and regulating hyaluronan secretion. J Leukoc Biol. 2021.
6. Chen Rong, Cao Yuwen, Tian Yu, Gu Yufeng, Lu Hongxiang, Zhang Shiqing, Xu Huaxi, Su Zhaoliang. PGE2 ameliorated viral myocarditis development and promoted IL-10-producing regulatory B cell expansion via MAPKs/AKT-AP1 axis or AhR signaling. Cell Immunol. 2020.
7. Lu Hongxiang, Chen Rong, Barnie Prince Amoah, Tian Yu, Zhang Shiqing, Xu Huaxi, Chakrabarti Subrata, Su Zhaoliang. Fibroblast transdifferentiation promotes conversion of M1 macrophages and replenishment of cardiac resident macrophages following cardiac injury in mice. Eur J Immunol. 2020.